Influences of APOE ε4 and Expertise on Performance of Older Pilots

Psychology and Aging

Volumn 26, Issue 2, 2011, Pages 480-487

  Taylor, Joy L ^a,b   Kennedy, Quinn ^b   Adamson, Maheen M ^a,b   Lazzeroni, Laura C ^b   Noda, Art ^b   Murphy, Greer M ^b   Yesavage, Jerome A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cognitive aging; Dementia; Gene environment interaction

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AVIATION; COGNITION; FEMALE; HETEROZYGOTE; HUMAN; MALE; MEMORY; NORMAL HUMAN; PILOT STUDY;

ADULT; AGE FACTORS; AGED; AIRCRAFT; APOLIPOPROTEIN E4; FEMALE; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MALE; MENTAL RECALL; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE;

EID: 79959299241     PISSN: 08827974     EISSN: 19391498     Source Type: Journal    
DOI: 10.1037/a0021697     Document Type: Article

References (39)

1. Adamson M.M., Landy K.M., Duong S., Fox-Bosetti S., Ashford J.W., Murphy G.M. Apolipoprotein E epsilon4 influences on episodic recall and brain structures in aging pilots. Neurobiology of Aging 2010, 31:1059-1063. doi: S0197-4580(08)00261-3[pii]10.1016/j.neurobiolaging.2008.07.017.
2. Arai T., Ikeda K., Akiyama H., Haga C., Usami M., Sahara N. A high incidence of apolipoprotein E epsilon4 allele in middle-aged non-demented subjects with cerebral amyloid beta protein deposits. Acta Neuropathologica 1999, 97:82-84. doi: 10.1007/s004010050958.
3. Blair C.K., Folsom A.R., Knopman D.S., Bray M.S., Mosley T.H., Boerwinkle E. APOE genotype and cognitive decline in a middle-aged cohort. Neurology 2005, 64:268-276.
4. Bunce D. APOE and cognitive function in nondemented old age: A genetic basis for brain or cognitive reserve?. Frontiers in Alzheimer's disease research 2006, 309-332. Nova Science Publishers, New York. E.M. Welsh (Ed.).
5. Carmelli D., Swan G.E., Reed T., Miller B., Wolf P.A., Jarvik G.P. Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins. Neurology 1998, 50:1580-1585.
6. Caselli R.J., Dueck A.C., Osborne D., Sabbagh M.N., Connor D.J., Ahern G.L. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. New England Journal of Medicine 2009, 361:255-263. doi: 361/3/255[pii]10.1056/NEJMoa0809437.
7. Caselli R.J., Reiman E.M., Osborne D., Hentz J.G., Baxter L.C., Hernandez J.L. Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology 2004, 62:1990-1995.
8. Cohen R.M., Small C., Lalonde F., Friz J., Sunderland T. Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology 2001, 57:2223-2228.
9. Dik M.G., Jonker C., Bouter L.M., Geerlings M.I., van Kamp G.J., Deeg D.J. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly. Neurology 2000, 54:1492-1497.
10. Ericsson K.W., Lehmann A.C. Expert and exceptional performance: Evidence of maximal adaptation to task constraints. Annual Review of Psychology 1996, 47:273-305. doi: 10.1146/annurev.psych.47.1.273.
11. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Journal of the American Medical Association 1997, 278:1349-1356. doi: 10.1001/jama.278.16.1349.
12. Ghebremedhin E., Schultz C., Braak E., Braak H. High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes. Experimental Neurology 1998, 153:152-155. doi: 10.1006/exnr.1998.6860.
13. Greenwood P.M., Sunderland T., Putnam K., Levy J., Parasuraman R. Scaling of visuospatial attention undergoes differential longitudinal change as a function of APOE genotype prior to old age: Results from the NIMH BIOCARD study. Neuropsychology 2005, 19:830-840. doi: 10.1037/0894-4105.19.6.830.
14. Haan M.N., Shemanski L., Jagust W.J., Manolio T.A., Kuller L. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. Journal of the American Medical Association 1999, 282:40-46. doi: 10.1001/jama.282.1.40.
15. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. Journal of Lipid Research 1990, 31:545-548.
16. Kay G.G. CogScreen Aeromedical edition professional manual 1995, Psychological Assessment Resources, Odessa, FL.
17. Kozauer N.A., Mielke M.M., Chan G.K., Rebok G.W., Lyketsos C.G. Apolipoprotein E genotype and lifetime cognitive decline. International Psychogeriatrics 2008, 20:109-123. doi: 10.1017/S104161020700587X.
18. Kraemer H.C., Blasey C.M. Centring in regression analyses: A strategy to prevent errors in statistical inference. International Journal of Methods in Psychiatric Research 2004, 13:141-151. doi: 10.1002/mpr.170.
19. Krampe R.T. Aging, expertise and fine motor movement. Neuroscience and Biobehavioral Reviews 2002, 26:769-776. doi: 10.1016/S0149-7634(02)00064-7.
20. Krampe R.T., Ericsson K.A. Maintaining excellence: Deliberate practice and elite performance in young and older pianists. Journal of Experimental Psychology General 1996, 125:331-359. doi: 10.1037/0096-3445.125.4.331.
21. Lemaitre H., Crivello F., Dufouil C., Grassiot B., Tzourio C., Alperovitch A. No epsilon4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. Neuroimage 2005, 24:1205-1213. doi: 10.1016/j.neuroimage.2004.10.016.
22. Masunaga H., Horn J. Expertise and age-related changes in components of intelligence. Psychology and Aging 2001, 16:293-311. doi: 10.1037/0882-7974.16.2.293.
23. Mayeux R., Small S.A., Tang M., Tycko B., Stern Y. Memory performance in healthy elderly without Alzheimer's disease: Effects of time and apolipoprotein-E. Neurobiology of Aging 2001, 22:683-689. doi: 10.1016/S0197-4580(01)00223-8.
24. Moffat S.D., Szekely C.A., Zonderman A.B., Kabani N.J., Resnick S.M. Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype. Neurology 2000, 55:134-136.
25. Mortensen E.L., Hogh P. A gender difference in the association between APOE genotype and age-related cognitive decline. Neurology 2001, 57:89-95.
26. Murphy G.M., Taylor J., Kraemer H.C., Yesavage J., Tinklenberg J.R. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease. American Journal of Psychiatry 1997, 154:603-608.
27. Nilsson L.G., Adolfsson R., Backman L., Cruts M., Nyberg L., Small B.J. The influence of APOE status on episodic and semantic memory: Data from a population-based study. Neuropsychology 2006, 20:645-657. doi: 10.1037/0894-4105.20.6.645.
28. Niti M., Yap K.B., Kua E.H., Tan C.H., Ng T.P. Physical, social and productive leisure activities, cognitive decline and interaction with APOE-epsilon 4 genotype in Chinese older adults. International Psychogeriatrics 2008, 20:237-251. doi: 10.1017/S1041610207006655.
29. Pendleton N., Payton A., van den Boogerd E.H., Holland F., Diggle P., Rabbitt P.M. Apolipoprotein E genotype does not predict decline in intelligence in healthy older adults. Neuroscience Letters 2002, 324:74-76. doi: 10.1016/S0304-3940(02)00135-0.
30. Reynolds C.A., Prince J.A., Feuk L., Brookes A.J., Gatz M., Pedersen N.L. Longitudinal memory performance during normal aging: Twin association models of APOE and other Alzheimer candidate genes. Behavior Genetics 2006, 36:185-194. doi: 10.1007/s10519-005-9027-6.
31. Slooter A.J., van Duijn C.M., Bots M.L., Ott A., Breteler M.B., De Voecht J. Apolipoprotein E genotype, atherosclerosis, and cognitive decline: The Rotterdam Study. Journal of Neural Transmission Supplementum 1998, 53:17-29.
32. Small B.J., Rosnick C.B., Fratiglioni L., Backman L. Apolipoprotein E and cognitive performance: A meta-analysis. Psychology and Aging 2004, 19:592-600. doi: 10.1037/0882-7974.19.4.592.
33. Taylor J.L., Kennedy Q., Noda A., Yesavage J.A. Pilot age and expertise predict flight simulator performance: A 3-year longitudinal study. Neurology 2007, 68:648-654. doi: 10.1212/01.wnl.0000255943.10045.c0.
34. Taylor J.L., O'Hara R., Mumenthaler M.S., Yesavage J.A. Relationship of CogScreen-AE to flight simulator performance and pilot age. Aviation, Space, and Environmental Medicine 2000, 71(April):373-380.
35. Taylor J.L., O'Hara R., Mumenthaler M.S., Rosen A.C., Yesavage J.A. Cognitive ability, expertise, and age differences in following air-traffic control instructions. Psychology and Aging 2005, 20:117-133. doi: 10.1037/0882-7974.20.1.117.
36. Tervo S., Kivipelto M., Hanninen T., Vanhanen M., Hallikainen M., Mannermaa A. Incidence and risk factors for mild cognitive impairment: A population-based three-year follow-up study of cognitively healthy elderly subjects. Dementia and Geriatric Cognitive Disorders 2004, 17:196-203. doi: 10.1159/000076356.
37. Tupler L.A., Krishnan K.R., Greenberg D.L., Marcovina S.M., Payne M.E., MacFall J.R. Predicting memory decline in normal elderly: Genetics, MRI, and cognitive reserve. Neurobiology of Aging 2007, 28:1644-1656. doi: 10.1016/j.neurobiolaging.2006.07.001.
38. Warzok R.W., Kessler C., Apel G., Schwarz A., Egensperger R., Schreiber D. Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly. Alzheimer Disease and Associated Disorders 1998, 12:33-39. doi: 10.1097/00002093-199803000-00005.
39. Yesavage J.A., Taylor J.L., Mumenthaler M.S., Noda A., O'Hara R. Relationship of age and simulated flight performance. Journal of the American Geriatric Society 1999, 47:819-823.